Premiums In Plans That Cap Insulin Costs Double Those That Don’t

Premiums in Medicare plans that cap monthly out-of-pocket insulin costs are nearly twice that of plans that don’t cap costs, according to a Kaiser Family Foundation analysis. The House was poised on Thursday (March 31) to vote on a bill to cap monthly insulin costs, but many lobbyists consider insulin cost caps a policy that appeases voters without curbing prices for even insulins, never mind other drugs. “For the subset of enhanced PDPs participating in the $35 copay insulin model,...
Article Type: 
Site Name: 
InsideHealthPolicy.com
IDP Issue: 
Inside Drug Pricing - 04/04/2022
IDP Volume: 
Vol. 5, No. 14
Author: 




HHS Chief Seeks Congress’ Help To Allow Interstate Licensing For Telehealth

HHS Xavier Becerra is seeking help from lawmakers in allowing interstate licensing of medical professionals so that telehealth can be practiced across state lines when the pandemic ends. Becerra’s request comes as telehealth stakeholders lobby federal and state lawmakers to take steps to extend flexibilities that have allowed health care delivery across state lines during the COVID-19 public health emergency. At a House Appropriations Committee budget hearing Thursday (March 31), Becerra said in addition to targeting rural and underserved areas...
Article Type: 
Site Name: 
InsideHealthPolicy.com
Author: 
Topics: 

Insurers Urge Lawmakers To Keep Telehealth Payment Parity Out Of Permanent Reforms

Key health insurance lobbies want federal and state lawmakers to steer clear of requiring payment parity between telehealth and in-person visits as they craft permanent telehealth reforms, but some stakeholders disagree. Medicare enforced telehealth payment parity in pandemic telehealth flexibilities and insurers, backed by some telehealth groups, argue such parity should not be made permanent because virtual services do not require the same equipment and time as in-person visits. The recently enacted omnibus spending bill extends pandemic telehealth flexibilities for...
Article Type: 
Site Name: 
InsideHealthPolicy.com
Author: 
Topics: 




Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.